J. Biol. Chem., Vol. 267, Issue 24, 16951-16956, Aug, 1992
L1210/B23.1 cells express equilibrative, inhibitor-sensitive nucleoside transport activity and lack two parental nucleoside transport activities
D Vijayalakshmi, L Dagnino, JA Belt, WP Gati, CE Cass and AR Paterson
Department of Pharmacology, University of Alberta, Edmonton, Canada.
Cultured mouse leukemia L1210 cells express the nucleoside-specific
membrane transport processes designated es, ei, and cif. The es and ei
processes are equilibrative, but may be distinguished by the high
sensitivity of the former to 6-[(4-nitrobenzyl)thio]-9-beta-D-
ribofuranosylpurine (NBMPR); the cif process is mediated by a
Na+/nucleoside cotransporter of low sensitivity to NBMPR. Cells of an
ei-deficient clonal line, L1210/MC5-1, were mutagenized, and clones were
selected in soft agar medium that contained (i) NBMPR (an inhibitor of es
processes), (ii) erythro-9-(2-hydorxy-3-nonyl)adenine (an inhibitor of
adenosine deaminase), and (iii) arabinofuranosyladenine (a cytotoxic
substrate for the three nucleotide transporters). The selection medium did
not allow es activity and selected against cells that expressed the
Na(+)-linked cif process. Cells of the L1210/B23.1 clonal isolate were
deficient in cif transport activity, and inward fluxes of formycin B, a
poorly metabolized analog of inosine, were virtually abolished by NBMPR in
these cells. In the mutant cells, nonisotopic formycin B behaved as a
countertransport substrate during influx of [3H]formycin B, and inward
fluxes of the latter were competitively inhibited by purine and pyrimidine
nucleosides. The transport behavior of L1210/B23.1 cells indicates that (i)
the mutation/selection procedure impaired or deleted the Na(+)- linked cif
process and (ii) es nucleoside transport activity is expressed in the
mutant cells.